Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Optobionics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Optobionics

Optobionics

Series A

Optobionics Corp: Pioneering vision loss solutions with ASR microchips since 1990.

HQ
Glen Ellyn, IL, US
Founded
1990
Overview
Compare
Fundraising
Employees
Website

Optobionics Corp, founded in 1990 and based in Glen Ellyn, Illinois, is dedicated to developing innovative solutions for vision loss. The company specializes in designing and manufacturing artificial silicon retina (ASR) microchips that stimulate damaged retinal cells, offering hope to patients with conditions like Retinitis Pigmentosa. Under the leadership of Dr. Chow, Optobionics continues to advance its mission of restoring vision through cutting-edge technology.

Optobionics has made significant strides in the field of ophthalmology with its pioneering ASR implants. The company's efforts have been instrumental in providing potential treatment options for individuals suffering from severe retinal conditions. By focusing on technological innovation and patient care, Optobionics has established itself as a leader in vision restoration solutions.

Optobionics - Similar Companies

Ocutronics logo

Ocutronics

MicroOptx logo

MicroOptx

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Optovue logo

Optovue

Neuroptics logo

Neuroptics

neuroptics.com

Iscience Surgical logo

Iscience Surgical

Sight Sciences logo

Sight Sciences

sightsciences.com

Opticent Health logo

Opticent Health

opticenthealth.com

IrisVision logo

IrisVision

irisvision.com

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Ocular Science logo

Ocular Science

ocularscience.com

Forsight Vision6 logo

Forsight Vision6

Advanced Optronics logo

Advanced Optronics

Corinthian Ophthalmic logo

Corinthian Ophthalmic

Retina Technologies logo

Retina Technologies

Optobionics - Quick Facts

Who are Optobionics' competitors?

Companies similar to Optobionics include Ocutronics, MicroOptx, Bioxytech Retina and Optovue.

When was Optobionics founded?

Optobionics was founded in 1990.

Where is Optobionics' headquarters located?

Optobionics' headquarters is located in Glen Ellyn, IL, US.

When was Optobionics' last funding round?

Optobionics' most recent funding round was for $4M (USD) in October 2000.

How much has Optobionics raised to-date?

As of Oct 23, 2000, Optobionics has raised a total of $4M (USD).

How many employees does Optobionics have?

Optobionics has 5 employees as of Feb 4, 2024.

Optobionics - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified